The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHD

Investigating the effects of methylphenidate and atomoxetine on emotional intelligence, excutive function and self-efficacy of 12-18-year-old adolescents withThe effect of methylphenidate and automoxetine on emotional intelligence, executive function and self-efficacy of adolescents aged 12 to 18 years with Attention Deficit Hyperactivity Disorder (ADHD)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160523028008N31

Enrollment

Registered

2024-02-21

Start date

2024-02-28

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder (ADHD). Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: The medication Ritalin, manufactured by Kareen (Iran), is initially prescribed at a dose of three-tenths of a milligram per kilogram of body weight per day. Subsequ

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Consent to participation in the study by parents Ages 12 to 18 years Suffering from Attention Deficit Hyperactivity Disorder (ADHD)

Exclusion criteria

Exclusion criteria: The existence of a range of psychotic disorders Autism spectrum disorders Severe physical illnesses intellectual disability

Design outcomes

Primary

Measure	Time frame
Emotional Intelligence. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Schutt Revised Emotional Intelligence Questionnaire (MSIS).;Executive Function. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Behavior Rating Inventory of Executive Function - Second Edition (BRIEF-2).;Self-Efficacy. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: The Self-Efficacy Questionnaire for Children and Adolescents (SEQ-C).	—

Measure

Time frame

Emotional Intelligence. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Schutt Revised Emotional Intelligence Questionnaire (MSIS).;Executive Function. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Behavior Rating Inventory of Executive Function - Second Edition (BRIEF-2).;Self-Efficacy. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: The Self-Efficacy Questionnaire for Children and Adolescents (SEQ-C).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Tavkoli

Hamedan University of Medical Sciences

tavkoliparisa08@gmail.com+98 81 1828 5015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026